Two new independent directors join Molbio

Molbio Diagnostics, a diagnostics player, announced the appointment of two independent directors to its board, Balram Bhargava and Arun Kumar Jha. These appointments come as the company continues to strengthen its leadership, says a company statement.
"These appointments reflect Molbio Diagnostics’ commitment to bringing on board leaders who are at the forefront of healthcare innovation and public health policy," said Sriram Natarajan, director and CEO of Molbio Diagnostics.
``Dr Jha and Dr Bhargava’s impressive backgrounds and shared dedication to improving healthcare access aligns perfectly with our vision of transforming global health landscapes," he added.